Webinar – Speed Without Compromise: From Complex Antibodies to Targeted Delivery
The next wave of antibody therapeutics is moving beyond conventional monoclonal antibodies. Antibody fragments, targeted delivery technologies, and increasingly complex formats are reshaping what's possible in drug development.
But innovation alone is not enough. Success depends on balancing molecular complexity with developability, manufacturability, robust CMC strategies, and speed to clinic.
Join ProBio experts as they share practical strategies for transforming next-generation antibody concepts into development-ready therapeutics.
Speaker
Topic
Dr. Ying Li
Director, Biologics Process Development
From VHH to LNP: Antibody Fragment Development Enabling Targeted Delivery
Dr. Leon Tian
Director, Biologics SME
Speed Without Compromise: Accelerating Complex Biologics Development
